Ellevest Inc’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13
Closed 1462
2022
Q1
$0 Sell
13
-16
-55% -$297 ﹤0.01% 1475
2021
Q4
$1K Hold
29
﹤0.01% 1265
2021
Q3
$1K Sell
29
-3
-9% -$164 ﹤0.01% 1253
2021
Q2
$2K Buy
32
+3
+10% +$111 ﹤0.01% 1028
2021
Q1
$1K Hold
29
﹤0.01% 1142
2020
Q4
$2K Buy
29
+11
+61% +$452 ﹤0.01% 962
2020
Q3
$1K Buy
18
+12
+200% +$391 ﹤0.01% 992
2020
Q2
$0 Buy
+6
New +$157 ﹤0.01% 1176
2020
Q1
Sell
-37
Closed -$1K 1135
2019
Q4
$1K Buy
+37
New +$924 ﹤0.01% 764

Other funds holding EDIT

Ellevest Inc's EDIT Position: Q2 2022 in Review

Ellevest Inc sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 13 shares.

Ellevest Inc first reported a position in EDIT in Q4 2019 and held it in 9 quarters. The position peaked at $2K in Q2 2021. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • Ellevest Inc reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • Ellevest Inc sold 13 Editas Medicine shares in Q2 2022.
  • Ellevest Inc first reported a position in Editas Medicine in Q4 2019 and held it in 9 quarters.
  • Ellevest Inc's Editas Medicine position peaked at $2K in Q2 2021.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on Ellevest Inc's 13F filing for Q2 2022, filed 18 Jul 2022.